Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Emilio Galcerá"'
Autor:
Edgardo Alania-Torres, Herminio Morillas-Climent, Alexandre García-Escrivá, Paul Vinueza-Buitrón, Inmaculada Poquet-Catalá, Esther Zorio, Ignacio José Sánchez-Lázaro, Emilio Galcerá-Jornet, Alfonso Valle-Muñoz
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the
Externí odkaz:
https://doaj.org/article/60ab4216056c442dadba0ce44bffb426
Autor:
Herminio Morillas, Emilio Galcerá, Edgardo Alania, Julia Seller, Ainhoa Larumbe, Julio Núñez, Alfonso Valle
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 4, p 139 (2022)
Sodium-glucose co-transporter 2 (SGLT2) inhibitors were initially conceived as glucose-lowering agents. However, striking renal and cardiovascular benefits were observed in type 2 diabetes trials. This led to evaluate it in dedicated studies in chron
Externí odkaz:
https://doaj.org/article/d5504ecc9589408faa87b10ea6a8ca32
Publikováno v:
In Revista española de cardiología suplementos 2014 14 Supplement 1:24-31
Autor:
Luciano Consuegra-Sánchez, A. Padilla‐Serrano, Samantha Wasniewski, Marta Vicente-Gilabert, Emilio Galcerá-Jornet, Antonio Melgarejo-Moreno, Juan Ramón Gimeno-Blanes, José de Gea-García, Leticia Jaulent-Huertas, José Galcerá-Tomás
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 10:918-925
Funding Acknowledgements Type of funding sources: None. Background New-onset right bundle branch block (RBBB) in myocardial infarction (MI) is often associated with ventricular fibrillation (VF) but the nature of this relationship has not been determ
Autor:
Alexandre García-Escrivá, Esther Zorio, Alfonso Valle-Muñoz, Ignacio Sánchez-Lázaro, Edgardo Alania-Torres, Emilio Galcerá-Jornet, Inmaculada Poquet-Catalá, Herminio Morillas-Climent, Paul Vinueza-Buitrón
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the
Autor:
Alfonso Valle, Julio Núñez, Ainhoa Larumbe, Julia Seller, Edgardo Alania, Emilio Galcerá, Herminio Morillas
Publikováno v:
Reviews in Cardiovascular Medicine. 23:139
Autor:
Ainhoa Larumbe-Rodríguez, Edgard Alania-Torres, Emilio Galcerá-Jornet, Herminio Morillas-Climent, Julia Seller-Moya, Álvaro Vicedo-López, Ydelise Rodríguez-Pichardo, Alfonso Valle-Muñoz
Publikováno v:
Journal of comparative effectiveness research. 8(9)
Aim: To analyze the impact of sacubitril/valsartan on functional class, surrogate parameters and clinical outcomes in clinical practice. Methods: Retrospective study of patients with heart failure and reduced ejection fraction that started treatment
Autor:
José Valencia, Pascual Bordes, Gregory Y.H. Lip, Vicente Mainar, Javier Pineda, Francisco Sogorb, Juan M. Ruiz-Nodar, José M. Gómez-Sansano, David Ramos, Emilio Galcerá
Publikováno v:
International Journal of Cardiology. 212:371-376
The reduction of delay times as well as the rate of false alarms (FA) have become some of the main points of the different infarction networks. We propose a simple way of classifying patients derived for primary PCI (pPCI) into well-defined simple gr
Autor:
Antonio Melgarejo-Moreno, Nuria Alonso-Fernández, Luciano Consuegra-Sánchez, Leticia Jaulent-Huertas, Eduardo Pinar-Bermudez, José de Gea-García, Emilio Galcerá-Jornet, José Galcerá-Tomás, Marta Vicente-Gilabert, A. Padilla‐Serrano, Ángela Díaz-Pastor, Germán Escudero-García
Publikováno v:
The American Journal of Cardiology. 116:1003-1009
The aim of this study was to investigate the prognosis associated with bundle branch block (BBB) depending on location, time of appearance, and duration in patients with myocardial infarction (MI). From January 1998 to January 2008, we recruited 5,57
Publikováno v:
Revista Española de Cardiología Suplementos. 14:24-31
Resumen La antiagregacion en el infarto agudo de miocardio con elevacion del segmento ST es uno de los aspectos que mas ha cambiado en los ultimos anos. Despues de mas de una decada en que la pauta era acido acetilsalicilico y clopidogrel tanto en la